Okayama Igakkai Zasshi (Journal of Okayama Medical Association)
Online ISSN : 1882-4528
Print ISSN : 0030-1558
Hypoplastic leukemia
Chemotherapy for bone marrow dysplasia
Shunichi FUKUDA
Author information
JOURNAL FREE ACCESS

1994 Volume 106 Issue 1-2 Pages 93-102

Details
Abstract
The effect of chemotherapy on dysplasia of bone marrow cells was studied in 10 patients with hypoplastic leukemia. Patients were all previously untreated, and ages ranged from 40 to 81 years old (median: 70). Male to female ratio was 1:1. Morphologic features studied were pseudo-Pelger neutrophils, absence or decreased Azur granules in the neutrophils, multinucleated erythroblasts, megaloblastoid changes in erythroblasts, micromegakaryocytes, mononuclear megakaryocytes and megakaryocytes with multiple small separated nuclei. Although 8 patients with chemotherapeutic effect showed little evidence of dysplasia, 2 patients without chemotherapeutic effect showed severe dysplasia in two or three blood cell lineages. These findings are thought to indicate that a part of hypoplastic leukemia develops from myelodysplasia with hypoplastic marrow. The establishment of an optimal treatment for hypoplastic leukemia should be studied by stratification of bone marrow dysplasia.
Content from these authors
© Okayama Medical Association
Previous article Next article
feedback
Top